Search Results 1721-1730 of 11175 for total t4

1. Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction - Mayo Clinic

   About this study. A randomized, double-blinded, placebo-controlled crossover study to assess effect of isosorbide mononitrate with dose up-titration on ...

2. Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations - Mayo Clinic

   Major surgery, other than diagnostic surgery, within 4 weeks prior to Cycle 1 Day 1, without complete recovery. Active, uncontrolled bacterial, viral, or ...

3. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

   Total bilirubin ≤ 1.5 × upper limit of normal (ULN) or ≤ 3xULN with documented Gilbert's syndrome;; Aspartate aminotransferase (AST) and alanine ...

4. The Partner II Trial: A Study of the Placement of Aortic Transcatheter Valves - Mayo Clinic

   Evidence of an acute myocardial infarction ≤ 1 month (30 days) before the intended treatment,defined as. Q wave MI; Non-Q wave MI with total CK elevation of ...

5. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

   Total bilirubin ≤ 1.5 times the upper limit of normal (ULN). Subjects with Gilbert's syndrome with bilirubin > 1.5 × ULN allowed per discussion with the ...

6. Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery - Mayo Clinic

   Total bilirubin ≤ 1.5 x upper limit of normal (ULN), unless due to Gilbert's disease;; Aspartate transaminase (AST/SGOT) and alanine transaminase (ALT/SGPT) ...

7. Neurology - Clinical trials

   ... total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...

8. Bladder Removal Surgery Clinical Trials - Mayo Clinic Research

   The dual primary hypotheses are preoperative EV + pembrolizumab and RC + PLND (Arm A) will achieve superior pathologic complete response (pCR) rate and ...

9. Phase I/II Study Of The Combination Of Blinatumomab And Asciminib In Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia - Mayo Clinic

   Total serum bilirubin ≤ 2 x upper limit of normal (ULN), unless due to Gilbert's syndrome 2. Alanine aminotransferase (ALT) ≤ 3 x ULN, OR 3. Aspartate ...

10. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia - Mayo Clinic

    Total bilirubin ≤1.5 x ULN (except for subjects with documented Gilbert's syndrome, in which case direct bilirubin must be ≤ 2 x ULN). Alanine ...